secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nautilus Biotechnology, Inc. (NAUT)
CIK:        0001808805
Form:       8-K
Filed at:   2023-06-15T23:59:59+00:00
Accession:  0001808805-23-000050
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Nautilus Biotechnology holds 2023 annual meeting; reelects three Class II directors
--------------------------------------------------------------------------------

- Stockholders elected Parag Mallick, Matthew McIlwain, and Farzad Nazem as Class II directors with >92M votes for each.
- Ratified PricewaterhouseCoopers LLP as independent auditor for FY2023 with 108.8M votes for, 299k against.
- Approximately 109.2M shares represented out of 124.9M outstanding as of April 17, 2023.
- No other business items or significant developments reported.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1808805/000180880523000050/0001808805-23-000050-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1808805/000180880523000050/naut-20230614.htm
  HTML page:      https://secwatch.observer/filing/0001808805-23-000050

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer